BioCentury
ARTICLE | Clinical News

MIV-711: Phase I started

June 4, 2012 7:00 AM UTC

Medivir began a double-blind, placebo-controlled, U.K. Phase I trial to evaluate oral MIV-711 in about 66 healthy volunteers. The trial will evaluate single-ascending doses of oral MIV-711 followed by...